Next Article in Journal
Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide
Previous Article in Journal
Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Salivary Histamine Levels in Patients with Oral Lichen Planus Lesions

by
Małgorzata Radwan-Oczko
1,
Anna Rybińska
1,
Agata Mierzwicka
2 and
Irena Duś-Ilnicka
1,*
1
Department of Oral Pathology, Wrocław Medical University, ul. Krakowska 26, 50-425 Wrocław, Poland
2
Department of Endocrinology, Diabetology and Isotope Treatment, Wybrzeże L. Pasteura 4, 50-367 Wrocław, Poland
*
Author to whom correspondence should be addressed.
Medicina 2024, 60(7), 1038; https://doi.org/10.3390/medicina60071038
Submission received: 20 May 2024 / Revised: 18 June 2024 / Accepted: 19 June 2024 / Published: 25 June 2024

Abstract

Background and Objectives: An oral lichen planus (OLP) chronic lesion refers to a group of oral potentially malignant disorders (OPMDs) that still lack a proper understanding from the point of view of relevant biomarkers for diagnostics and prognosis. The aim of the study was to assess the salivary histamine levels in patients with oral lichen planus lesions. Materials and Methods: The study included a group of 76 patients with oral lichen planus. General diseases and medication taken, smoking habits, severity of pain assessed using a visual analogue scale (VAS), oral hygiene status, and duration of OLP were evaluated. ELISA diagnostics for histamines in saliva levels were assessed. Results: The histamine levels in the OLP group were higher (0.468) in comparison with the control group (0.056), without a statistically significant value p = 0.090 (Mann–Whitney U Test). The median age of 76 OLP patients was 63 years (min 22.0–max. 81), with the biological sex being 80.3% females and 15 19.7% males. The average duration of OLP lesion presence was 29.4 months (SD 37.1) and the median value was 14.5 months. The median of the VAS was 3.0. OLP assessment in accordance with the Malhotra methodology showed the highest frequency—30.3% for only two of the point areas involved and 17.1% for three points. Clinical assessment of the different OLP grades, severity, and oral site involvement and the VAS in correlation with histamine salivary levels showed a lack of statistical significance in the investigated population. Conclusions: Undertaking further research could provide further possibilities for searching for general factors in OLP development.
Keywords: histamine; lichen planus; oral; saliva; autoimmune disease; salivary proteins histamine; lichen planus; oral; saliva; autoimmune disease; salivary proteins

Share and Cite

MDPI and ACS Style

Radwan-Oczko, M.; Rybińska, A.; Mierzwicka, A.; Duś-Ilnicka, I. Salivary Histamine Levels in Patients with Oral Lichen Planus Lesions. Medicina 2024, 60, 1038. https://doi.org/10.3390/medicina60071038

AMA Style

Radwan-Oczko M, Rybińska A, Mierzwicka A, Duś-Ilnicka I. Salivary Histamine Levels in Patients with Oral Lichen Planus Lesions. Medicina. 2024; 60(7):1038. https://doi.org/10.3390/medicina60071038

Chicago/Turabian Style

Radwan-Oczko, Małgorzata, Anna Rybińska, Agata Mierzwicka, and Irena Duś-Ilnicka. 2024. "Salivary Histamine Levels in Patients with Oral Lichen Planus Lesions" Medicina 60, no. 7: 1038. https://doi.org/10.3390/medicina60071038

Article Metrics

Back to TopTop